COVID-19 infection could be underlying trigger for many other health complications such as heart failure, respiratory failure, stroke, and inflammatory syndromes.
A comprehensive test package to monitor your immune system for evaluation of biomarkers which may lead to manifestation of disease after COVID-19 infection.
D-Dimer : Small fragment protein which increases with formation and breakdown of clots in the the body. D-Dimer testing in patients with COVID-19 is essential as it could be used as early marker to improve management of patients with COVID-19.
C-Reactive Protein (CRP) : Levels of CRP rises in response to inflammation in the body. Evaluation of infection and severity of inflammation could be done with measuring CRP levels.
Ferritin : As one of the makers of inflammation, ferritin levels highly correlate with severity of COVID-19. The elevated levels could be an underlying reason of secondary health complications.
CBC : Different components of the blood are checked in order to improve prognosis. Decreased levels of components like white blood cell, platelets and lymphocytes are linked to poor prognosis.
Interleukin-6 (IL-6) : Evaluation of IL-6 in the plasma can help in predicting & evaluating the outcome of inflammatory syndrome and sepsis.
Creatinine : Evaluation of this component could help in assessing acute kidney injury and to avoid long-term kidney related complications in patients with COVID-19.
Procalcitonin : Eleavted levels of this component is associated with increased tissue injury,sepsis and infection, hence evaluation of this biomarker is crucial.
Lactate Dehydrogenase (LDH) : Evaluation of LDH in plasma can help in recognising cytokine mediated tissue damage, which is associated with poor prognosis in COVID-19 patients.
N-terminal pro-B-type natriuretic peptide (NT-proBNO) & Troponin-1 (Trop-1) : Evaluation of these biomarker is essential to monitor heart related issues/cardiac injuries. Elevated levels are found to be associated with poor prognosis.